LIVZON PHARMACEUTICAL GROUP INC.

Livzon Pharmaceutical Group Inc. is a leading pharmaceutical enterprise with a mission to dedicate to the cause of human health and a vision to become the world’s leading pharmaceutical enterprise. Established in 1985 with registered capital of 953 million yuan, Livzon is a comprehensive pharmaceutical group company integrating pharmaceutical R&D, production, and sales, employing more than 9,000 employees. The company has demonstrated strong financial performance, with an annual operating revenue of 10.5 billion yuan in 2020, accompanied by a net profit of 2.131 billion yuan and an R&D investment of 989 million yuan. Livzon is committed to ensuring effective, safe, and stable products, with its pharmaceutical enterprises having established a sound quality management system. The company's dedication to quality is evident through the 31 production lines of 4 pharmaceutical subsidiaries that have passed GMP certification. In addition, 28 varieties of 4 API companies have also passed GMP certification, with 11 varieties obtaining veterinary medicine GMP certification. Notably, 15 API varieties have passed the field inspection of international certification and obtained 20 international certification certificates.